Free Delivery Over $100
|
|
|||
|
||||
OverviewThis book focuses on applications of compound library design and virtual screening to expand the bioactive chemical space, to target hopping of chemotypes to identify synergies within related drug discovery projects or to repurpose known drugs, to propose mechanism of action of compounds, or to identify off-target effects by cross-reactivity analysis. Both ligand-based and structure-based in silico approaches, as reviewed in this book, play important roles for all these applications. Computational chemogenomics is expected to increase the quality and productivity of drug discovery and lead to the discovery of new medicines. Full Product DetailsAuthor: Edgar Jacoby (Novartis Pharma AG, Basel, Switzerland) , Edgar Jacoby (Novartis Pharma AG, Basel, Switzerland)Publisher: Pan Stanford Imprint: Pan Stanford ISBN: 9781322631592ISBN 10: 132263159 Pages: 256 Publication Date: 01 January 2013 Audience: General/trade , General Format: Electronic book text Publisher's Status: Active Availability: In stock  We have confirmation that this item is in stock with the supplier. It will be ordered in for you and dispatched immediately. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
